1. Home
  2. KZIA vs OMH Comparison

KZIA vs OMH Comparison

Compare KZIA & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KZIA
  • OMH
  • Stock Information
  • Founded
  • KZIA 1994
  • OMH 2015
  • Country
  • KZIA Australia
  • OMH Singapore
  • Employees
  • KZIA N/A
  • OMH N/A
  • Industry
  • KZIA Biotechnology: Pharmaceutical Preparations
  • OMH Real Estate
  • Sector
  • KZIA Health Care
  • OMH Finance
  • Exchange
  • KZIA Nasdaq
  • OMH Nasdaq
  • Market Cap
  • KZIA 6.0M
  • OMH 8.0M
  • IPO Year
  • KZIA 1999
  • OMH 2023
  • Fundamental
  • Price
  • KZIA $0.89
  • OMH $0.38
  • Analyst Decision
  • KZIA Strong Buy
  • OMH Strong Buy
  • Analyst Count
  • KZIA 2
  • OMH 1
  • Target Price
  • KZIA $11.50
  • OMH $1.50
  • AVG Volume (30 Days)
  • KZIA 5.5M
  • OMH 141.6K
  • Earning Date
  • KZIA 03-26-2025
  • OMH 09-25-2024
  • Dividend Yield
  • KZIA N/A
  • OMH N/A
  • EPS Growth
  • KZIA N/A
  • OMH N/A
  • EPS
  • KZIA N/A
  • OMH N/A
  • Revenue
  • KZIA $1,655,324.00
  • OMH $5,390,607.00
  • Revenue This Year
  • KZIA $806.89
  • OMH $101.90
  • Revenue Next Year
  • KZIA N/A
  • OMH $38.34
  • P/E Ratio
  • KZIA N/A
  • OMH N/A
  • Revenue Growth
  • KZIA 248000.00
  • OMH 25.77
  • 52 Week Low
  • KZIA $0.89
  • OMH $0.32
  • 52 Week High
  • KZIA $15.80
  • OMH $1.19
  • Technical
  • Relative Strength Index (RSI)
  • KZIA 28.96
  • OMH 54.38
  • Support Level
  • KZIA $0.90
  • OMH $0.33
  • Resistance Level
  • KZIA $1.60
  • OMH $0.37
  • Average True Range (ATR)
  • KZIA 0.24
  • OMH 0.03
  • MACD
  • KZIA 0.01
  • OMH 0.00
  • Stochastic Oscillator
  • KZIA 0.00
  • OMH 46.97

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, Property Management Services, and revenue from emerging and other services.

Share on Social Networks: